The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a recurrent incisional hernia with incarcerated bowel.It was reported that after implant, the patient experienced pain, adhesions, hernia recurrence, bowel disruption, abdominal wall seroma, fistula, obstruction, exposed mesh, purulent discharge with foul odor, open abdominal wound, hematemesis, abdominal pain, nausea, vomiting, ischemia, fascitis, and infections.Post-operative patient treatment included revision surgeries, additional implant for recurrence repairs, incision and drainage of seroma, debridement, placement of wound vac, mesh removal, abdominal wound skin graft, exploratory laparotomy, extensive adhesiolysis, small bowel resection with anastamosis and abdominal wash out with 3 liters of saline.Information received indicates the patient is deceased.The patient expired due to cardio respiratory failure & acute renal disease.It is unknown at this time if the device caused or contributed to the event.
|